Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3681128018 | Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681129014 | Lovastatin 20 mg and nicotinic acid 750 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681130016 | Lovastatin 20 mg and niacin 750 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Lovastatin and niacin only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing lovastatin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing nicotinic acid (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Vitamin | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Lovastatin | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing lovastatin and nicotinic acid (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Niacin | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Vitamin B and/or vitamin B derivative (substance) | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Niacin | false | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Niacin | true | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 750 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Lovastatin | false | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Lovastatin | true | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 20 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing nicotinic acid in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Lovastatin | true | Inferred relationship | Some | 2 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Niacin | true | Inferred relationship | Some | 1 | |
| Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR